This contract expires in 111 days (Sep 30, 2026).
FIRM FIXED PRICE
NOVARTIS PHARMACEUTICALS CORPORATION - LUTATHERA AND PLUVICTO
PIID: W81K0025FA195
Signed Date: Dec 4, 2025Effective Date: Oct 1, 2025End Date: Closes in 111 days
Award $
$3.2M
Vendor
NOVARTIS PHARMACEUTICALS CORPORATION
NAICS
325412
Signed Date
Dec 4, 2025
Key Details
Description
LUTATHERA AND PLUVICTO
Context & Analysis
On Dec 4, 2025, Department of Defense obligated $3,232,079.59 to NOVARTIS PHARMACEUTICALS CORPORATION for lutathera and pluvicto. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: not competed. Performance is located in SAN ANTONIO, TX. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining.
Contractor Information
Contractor: NOVARTIS PHARMACEUTICALS CORPORATION
UEI: NG61ZA8TADW3
CAGE Code: 04520
Location: EAST HANOVER, NJ
Stay Updated
Get notified about new opportunities matching your interests.